Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | McElrath: Durability of HIV-Specific Protective Ab Response |
| Strategy: | Protein and peptide vaccines |
| Study Type: | Pre-Clinical Non-NHP |
| Species: | Guinea Pig |
| Stage: | Assays Completed |
| Study Start Date: | 2018-01-24 |
| Study Made Public: | 2020-01-29 |
Title
Antibody responses to HIV BG505 SOSIP.664 protein formulated with adjuvants in guinea pigs
Description
CAVD 708 is a preclinical guinea pig study assessing antibody responses to the HIV BG505 SOSIP.664 protein formulated with different adjuvants.
Sign in to see full information about this study and to download study data.
Products
QS-21 BG505 SOSIP.664 GLA-LSQ Adjuplex 3M-052 CpG 1018 AlhydrogelIntegrated data
BAMA, NAb
Non-integrated data
No non-integrated data is available for this study.